It is known that cells within the inflammatory background in classical Hodgkin Lymphoma (cHL) provide signals essential for the continual survival of the neoplastic Hodgkin and Reed-Sternberg (HRS) cells. However, the mechanisms underlying the recruitment of this inflammatory infiltrate into the involved lymph nodes are less well understood. In this study, we show in-vitro that HRS cells secrete Lymphotoxin-α (LTα) which acts on endothelial cells to up-regulate the expression of adhesion molecules that are important for T cell recruitment. LTα also enhances the expression of hyaluronan which preferentially contributes to the recruitment of CD4 + CD45RA + naïve T cells under in-vitro defined flow conditions. Enhanced expression of LTα in HRS cells and tissue stroma; and hyaluronan on endothelial cells are readily detected in involved lymph nodes from cHL patients. Our study also shows that although NFκB and AP-1 are involved, the Cyclooxygenase (COX) pathway is the dominant regulator of LTα production in HRS cells. Using pharmacological inhibitors, our data suggest that activity of COX1, but not of COX2, directly regulates the expression of nuclear c-Fos in HRS cells. Our findings suggest that HRS cell-derived LTα is an important mediator that contributes to T cell recruitment into lesional lymph nodes in cHL.
Introduction
Classical Hodgkin Lymphoma (cHL) is characterized by a paucity of malignant Hodgkin and Reed-Sternberg cells (HRS cells) embedded within an inflammatory infiltrate comprising CD4 + T cells, B cells, macrophages, granulocytes, and fibroblasts. HRS cells secrete numerous cytokines and chemokines that act collectively to recruit this cellular infiltrate which, in turn, is the source of various soluble factor-derived and membrane bound molecule-derived signals essential for the continued survival of the neoplastic cells 1-3 .
HRS cells originate from crippled post-germinal center B cells that have escaped apoptosis 4,5 .
They show aberrant signaling activities involving Nuclear Factor kappa B (NFκB) 6,7 , JAK-Stat 8-11 , Activator Protein 1 (AP-1) 12 , PI3K-Akt 13,14 and multiple receptor tyrosine kinases 15 . Deregulated NFκB and AP-1 pathways contribute significantly to the survival of HRS cells and the maintenance of an immunosuppressive microenvironment. Over-expression of components of the AP-1 transcription complex, such as JunB and c-Jun in HRS cells, results in the induction of many target genes to suppress anti-tumor T cell activity 16, 17 . Similarly, over-expression of the cyclooxygenase-2 (COX-2) enzyme is associated with enhanced angiogenesis in HL 18 .
Lymph node architecture and the protein microenvironment are important for regulation of lymphocyte recirculation and optimal immune response 19 . While tissue architecture is effaced in cHL activate endothelial cells to enhance leukocyte binding in-vitro 21 . This suggests that HRS cells are able to modulate endothelial function in the affected lymph node to enhance inflammatory cell recruitment. However, neither study identified the HRS cell-derived soluble factor(s) responsible.
Lymphotoxin-α (LTα) is a member of the tumour necrosis factor (TNF) superfamily, existing either as the soluble homotrimer, LTα 3, or as a membrane bound heterodimer, LTα 1 β 2 . LTα 3 is secreted by CD4 + Th1, CD8 + , natural killer (NK), B and lymphoid tissue inducer cells [22] [23] [24] . LTα 3 binds to and signals through the TNF receptors TNFRI and TNFRII, and exhibits overlapping biological activities with TNFα. LTα can induce ICAM-1 and E-selectin on endothelial cells in-vitro 25 or VCAM-1 in-vivo 26 . LTα is also required for the maintenance of lymphoid architecture and segregation of T and
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From B cells in adult lymph nodes 27, 28 . LTα gene expression has been found in cHL lymph nodes 29 , and HRS cells identified as a source of LTα 30 . However, the serum level of LTα is not elevated in cHL patients, nor is expression of LTα associated with B symptoms 31 .
In this study, we identify in-vitro HRS cell-derived LTα as the mediator that induces endothelial cell activation to enhance interaction with T cells. Binding of naive T cells to the LTα-activated endothelial monolayer is mediated by L-selectin-L-selectin ligand and CD44-hyaluronan adhesive pathways. We also identify NFκB, JNK/AP-1 and COX enzymatic pathways as the signaling pathways involved in LTα production in HRS cells. Our data is corroborated by demonstration of positive immunohistochemical staining for LTα expression in HRS cells, and of over-expression of hyaluronan in CD31 + endothelial cells within cHL lymph nodes.
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Materials and Methods

Cells and lymph nodes
HRS cell lines, KM-H2, L1236, L428 and L540 obtained from Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ) were maintained in supplemented RPMI 1640 media.
Endothelial cells (HUVEC) were isolated from human umbilical cords from consented donors as described previously 32 . The cells were maintained in Clonetics ® EBM2 Medium (Lonza) and used at passages 3-6.
CD4 + T cells were harvested from buffy coats of healthy donors using whole blood CD4 microbeads (Miltenyi Biotec). Naïve and memory T cells were then purified by negative selection using respectively anti-CD45RO-coated and anti-CD45RA-coated immunomagnetic beads (Invitrogen) as previously described 33 .
The use of freshly isolated cells and paraffinized lymph node sections from archival tissues of cHL patients from Singapore and United Arabs of Emirates was approved by ethics committees of respective institutions in accordance with the principles of the Declaration of Helsinki.
Preparation of culture supernatant (C/S)
2x10 6 HRS cells were cultured in 1ml of fresh RPMI 1640 complete media for 24 hours. C/S was used at a dilution of 1 in 2 or 1 in 8 for activation of endothelial cell monolayers.
To investigate the signaling pathways involved, KM-H2 cells were treated with Bay11-7085 (inhibitor of IkBα phosphorylation, Merck), SP600125 (inhibitor of JNK phosphorylation, Cayman Company), Celecoxib (selective Cox-2 inhibitor, Cayman Company) or Indomethacin (non-selective COX inhibitor, Sigma Aldrich) for 12 hours at the concentrations stated. Controls were untreated KM-H2 cells or KM-H2 cells treated with DMSO (vehicle) . LTα concentration in the C/S was measured by ELISA (eBioscience). Lysate from treated cells was analyzed by Western Blot.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Western blot 25μg of cytoplasmic or nuclear protein/lane was loaded onto 10% SDS-Page gel for p65 and c-Fos or 12% gel for JNK and c-Jun detection. Protein separation was carried out at 100V. Following protein transfer and blocking with 5% non-fat milk, blots were incubated overnight at 4°C with diluted primary antibodies. Incubation with secondary anti-rabbit or anti-mouse IgG HRP conjugate (Santa Cruz) was for 1 hour at room temperature prior to visualization by chemiluminescence (Merck Milipore). The following antibodies were used: anti-p65, anti-phosphorylated c-Fos (Santa Cruz); antitotal c-Fos, anti-phosphorylated JNK, anti-total JNK, anti-phosphorylated c-Jun, anti-total c-Jun (Cell Signaling). Blots were reprobed with an anti-beta actin antibody (Santa Cruz) as cytoplasmic loading control and anti-TATA box antibody (Abcam) as nuclear loading control.
TNF-α/LTα bioassay
The mouse fibroblast cell line, L929, which is sensitive to both TNF-α and LTα, was seeded into 96-well plates (5 x 10 3 cells/100µl/well) and maintained for 24 hours. Culture medium was replaced with diluted C/S from HRS cell lines at the dilutions indicated, and supplemented with Actinomycin D (0.2µg/ml). Cell viability was assessed after 12 hours by Cell Titre 96 Aqueous One Solution Cell Proliferation Assay (Promega Corporation). 10ng/ml TNF-α was included as positive control.
Neutralization of TNF-α and LTα was achieved by pre-treating the C/S with anti-TNF-α or anti-LTα neutralizing antibodies (R&D Systems) for 30 minutes at 37°C.
In-vitro flow T cell-HUVEC interaction analysis
T cell-endothelial cell interactions under defined flow conditions were examined using the parallel plate flow chamber system as described previously [32] [33] [34] Figure 1A shows that C/S from 3 out of 4 HRS cell lines, KM-H2, L1236 and L428, stimulated HUVEC to up-regulate expression of ICAM-1, VCAM-1 and E-selectin to levels comparable to that seen in TNFα-activated HUVEC. The stimulating factor(s) present in the C/S is secreted spontaneously and is of high efficacy (Supplemental Figure 1A and B ). This stimulatory effect is not due to endotoxin contamination or to serum components, as added polymyxin B and replacement with serum free culture medium did not inhibit its potency (Supplemental Figure 1C and D respectively). It is, however, heat-sensitive as boiling the C/S (5 minutes) completely negated its effect on HUVEC (Supplemental Figure 1D ).
Results
LT-α is a potent endothelial cell stimulant spontaneously secreted by HRS cells
Pre-treatment of HUVEC with NFĸB inhibitor, Bay11-7085, prior to C/S stimulation, reduced nuclear p65 expression with concurrent attenuation of ICAM-1, VCAM-1 and E-selectin expression on these cells compared to DMSO-treated HUVEC ( Figure 1B ). This suggests that activation of HUVEC by C/S is mediated via the NFκB pathway.
Since the C/S-stimulated endothelial cells showed functional similarity to their TNF-α-stimulated counterparts, the L929 mouse fibroblast cytotoxic assay was used to determine the presence of biologically active TNF-α in the HRS cell C/S. Interestingly, the C/S stimulatory effects of each HRS cell-derived C/S paralleled their cytotoxic effects on L929 cells. Incubation of L929 cells with C/S from KM-H2, L1236 and L428 cells but not from L540 resulted in extensive L929 cell death ( Figure 1C ).
The cytotoxic effect of KM-H2 C/S on L929 cells decreases with increasing dilution of the C/S ( Figure   1D , left panel). However, treatment of C/S with neutralizing mAb against TNF-α did not improve L929 cell survival, suggesting absence of TNF-α from the C/S. The concentration of mAb used is sufficient to neutralize 10ng/ml of recombinant human TNF-α ( Figure 1D LTα present in the C/S of KM-H2, L1236 and L428 cells ( Figure 1F ).
CD4 + CD45RA + naïve T cell binding to C/S-stimulated HUVEC is mediated by CD44-hyaluronan interactions
We next investigated whether C/S stimulated HUVEC monolayers would interact with T cells under defined flow conditions. Both CD4 + CD45RA + naïve and CD45RO + memory T cells were found to interact with C/S-stimulated HUVEC in a shear stress dependent manner (Figure 2A and B respectively). Both rolling and adhered phenotypes of T cells were identified (data not shown). The number of interacting CD4 + naive and memory T cells was comparable to that of TNF-α activated HUVEC under similar conditions. Neutralization of LTα in the C/S prior to HUVEC stimulation significantly reduced the number of T cell interactions ( Figure 2C and D).
Function blocking experiments were carried out to better understand the mechanisms underlying recruitment of naïve T cells in cHL. Treatment of C/S-stimulated HUVEC with mAb against ICAM-1 partially reduced the number of interacting CD4 + naïve T cells compared to C/S-stimulated HUVEC control or C/S-stimulated HUVEC treated with mAb against MHC class I molecules ( Figure   3A ). Treatment with mAb against VCAM-1 or E-selectin did not show similar reduction. Blocking of CD18, the β2-integrin subunit, but not of CD11a, on naïve T cells partially reduced their interactions with C/S-stimulated HUVEC ( Figure 3B ). Blocking of L-selectin also resulted in a partial reduction in the number of T cell interactions. This suggests that a novel adhesive pathway may be involved in mediating naïve T cell interactions with endothelial cells in the presence of HRS cell-derived factors.
CD44 is a cell surface glycoprotein expressed on many different cell types. Binding of CD44 to its ligand, hyaluronan (hyaluronic acid) could regulate T cell adhesion to endothelial cells under physiological flow conditions and in-vivo 35 . Blocking of CD44 on naïve T cells inhibited the number of T cell interactions with C/S-stimulated HUVEC by 78±14%, but not with TNF-α-stimulated HUVEC ( Figure 3C ). In contrast, blocking of CD44 on CD4 + CD45RO + memory T cells did not reduce the number of interactions with C/S-stimulated HUVEC, although there was a shift from arrested to the rolling phenotype (Data not shown).
Pretreatment of the C/S-stimulated HUVEC with hyaluronidase, but not with deactivated (boiled) hyaluronidase significantly reduced the number of interacting naïve T cells by 58±4% as compared to untreated C/S-stimulated HUVEC ( Figure 3D ). Since hyaluronan is a component of the endothelial
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Taken together, these in-vitro data indicate that HRS cells secrete LTα that in turn activates endothelial cells to up-regulate expression of adhesion molecules, including ICAM-1, VCAM-1, Eselectin and hyaluronan, to facilitate recruitment of T cells into cHL lymph nodes.
Increased LTα expression and enhanced hyaluronan expression is detected in cHL lymph
nodes.
We also examined LTα and hyaluronan expression in tissue sections from two cohorts of cHL patients (Singapore and United Arab Emirates). LTα expression was detected in HRS cells and in the extracellular stroma ( Figure 4A ). Intense LTα expression was detected in 11 of the 32 cases screened, 11 other cases showed moderate LTα expression and the remainder showed weak or negligible LTα staining ( Figure 4B -D). There was, however, no difference in LTα expression between the two patient cohorts.
To detect enhanced hyaluronan expression, tissue sections were probed with hyaluronic acid binding protein (HABP) and the resultant staining profile compared with that detected in reactive (nonmalignant) lymph nodes. Distinct labelling with HABP was seen in the germinal centers of B cell follicles and in the subendothelial layers of large vessels in the reactive lymph nodes ( Figure 4E ).
Punctate positivity was also detected in high endothelial venules (HEV, Figure 4F ) and thin walled vessels (Data not shown). Sections from cHL lymph nodes showed intense hyaluronan expression within the extracellular stroma, particularly in fibrotic areas, and membrane positivity in the HRS cells ( Figure 4G and Supplemental Figure 3 ). In contrast, staining intensity in the nodules was relatively weaker as many of the infiltrating lymphocytes exhibited low hyaluronan expression ( Figure 4G and Supplemental Figure 3 ). Treatment of the tissue sections with hyaluronidase completely abrogated such HABP labelling ( Figure 4H ). Two-color staining using anti-CD31 mAb and HABP showed colocalization of CD31 and HABP staining on vessel-like structures, thus confirming that high expression of hyaluronan is found on endothelial cell surfaces in cHL tissues ( Figure 4J For personal use only. on September 14, 2017. by guest www.bloodjournal.org From SP600125-treated KM-H2 cells produce lower amounts of LTα ( Figure 5F ), with maximum inhibition (44%±10%) achieved at 100μM. KM-H2 cells treated with 0.3mM of the non-selective COX inhibitor, Indomethacin, significantly reduced LTα production by 85%±3% compared to DMSO-treated or untreated KM-H2 cells ( Figure   6A ). In contrast, treatment of KM-H2 cells with Celecoxib, a selective COX2 inhibitor, did not exhibit such an effect over the range of doses tested ( Figure 6B ). Similarly, Indomethacin treated-L1236 and similarly-treated-L428 cells also showed the highest attenuation in LTα secretion compared to BAY11- Figure 4A To determine whether the AP-1 and COX pathways were acting synergistically, we compared the cytotoxic effect of the C/S harvested from KM-H2 cells treated with SP600125 alone, with Indomethacin alone or with both inhibitors simultaneously on L929 cells. Our data showed that For personal use only. on September 14, 2017. by guest www.bloodjournal.org From 1 2 treatment with SP600125 or Indomethacin partially neutralized the cytotoxic effect of the C/S on L929 cells by 42.7±5.2% and 59.4±5.9% respectively ( Figure 6C ). However, combination treatment with both inhibitors did not further improve L929 cell viability as compared to Indomethacin treatment alone. Thus, the COX pathway is the dominant regulator of LTα production by HRS cells.
7085-treated or SP600125-treated cells (Supplemental
NFκB and COX pathways converge at the regulation of phosphorylated-c-Fos expression
Immunohistochemical analysis of cHL tissues showed strong cytoplasmic c-Fos expression in HRS cells in-situ. Nuclear expression of c-Jun and c-Fos is also seen (Supplemental Figure 6 ). Since SP600125 treatment downregulated c-Jun expression but did not show any effect on phosphorylatedc-Fos expression ( Figure 5C and E), we next analyzed whether c-Fos expression is regulated by NFκB or COX pathways in HRS cells.
Indomethacin-treated KM-H2 cells showed a decrease in phosphorylated c-Fos with a concomitant increase in phosphorylated JNK and phosphorylated c-Jun expression ( Figure 7A -C).
Total JNK, total c-Jun and nuclear p65 expression remained unchanged in these cells thus suggesting inherent stress response (Data not shown). Similar loss of phosphorylated-c-Fos was also seen when the cells were treated with BAY11-7085 ( Figure 7D ). Hence, expression of phosphorylated-c-Fos in HRS cells may be regulated concomitantly by both NFκB and COX pathways. Our data suggest that the AP-1 c-Jun/c-Fos transcription complex in HRS cells is regulated concomitantly by JNK/AP-1, NFκB and COX pathways.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From 1 3 Discussion CHL is an enigma among lymphomas, as the neoplastic cells only comprise 1% of the cellular population of the lesion; the remainder being inflammatory cells recruited into the affected lymph node. While previous studies have reported on the chemokines secreted by HRS cells to attract these inflammatory cells 20, 38, 39 , it remains unclear how the endothelium within the lesion is modulated to enhance this inflammatory recruitment. In this study, we identify HRS cell-derived LT-α as a potent endothelial cell stimulant. We show that it augments endothelial cell adhesiveness towards naïve T cells via upregulation of inducible adhesion molecules and hyaluronan. Our data also implicate the NFκB, AP-1 and Cyclooxygenase pathways in the production of LTα by HRS cells.
Several studies have shown that soluble tumor cell mediators, including HRS cell-derived factors, can modulate endothelial cell function 21, 40 . Estrada-Bernal et al reported that soluble products derived from Hodgkin lymphoma cell lines are able to induce E-selectin expression on HUVEC as well as to enhance binding of U937 histiocytic cells 21 . Although U937 adherence to stimulated HUVEC was dependent on NFκB activation, E-selectin surprisingly did not play a role. The authors also concluded that the lymphoma-derived factor involved was neither TNF-α nor IL-1β. In this and other studies, the endothelial stimulatory factor(s) were not identified. In our study, we identify LTα as the endothelial stimulant in HRS cell C/S that activates HUVEC to enhance memory and naïve T cell adhesion. In-situ expression of LTα in HRS cells in cHL lymph nodes was also demonstrated in two cohorts of patients from Singapore and UAE, suggesting that this is not a culture induced phenomenon.
The production of TNF-α and LTα by HRS cell lines; and the cytotoxic effects of HRS cell C/S on L929 cells have been previously reported 30, 41, 42 However, there was no correlation between LTα mRNA expression and histologic type, histological criteria for necrosis, neoangiogenesis, hyalinosis, or B symptoms 29 . Consistent with these studies, our data also show that it is LTα, and not TNF-α, in C/S of the HRS cell lines that is inducing L929 cell death. We also show the presence of LTα in HRS cells in-situ by immunohistochemistry.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From 1 4
Warzocha et al also reported that plasma levels of LTα in HL patients with B symptoms were similar to those of healthy controls 31 . Our data suggest that the effect of LTα is likely to be acting locally on the stromal compartment rather than systemically. LTα has been shown to act on endothelial cells to induce a morphologic change from polygonal to fibroblastoid. This is associated with an increase in expression of inducible cell surface adhesion molecules important for leukocyte recruitment 25 . Consistent with this, we show that HRS cell-derived LTα can activate endothelial cells to enhance naive T cell binding. Function blocking studies confirm these interactions are mediated in part by ICAM-1 expressed on stimulated HUVEC, and by 55 . Here, we propose that high concentrations of LTα in the HRS cell-derived C/S or in the cHL lymph node could enhance hyaluronan expression on endothelial cells to induce naïve T cell recruitment.
As expected, the hyaluronan ligand expressed on the naive T cells is CD44. Interaction of CD44 and hyaluronan is well described for memory T cells, activated T cell subsets, and neutrophils 47 . While all forms of CD44 bind hyaluronan, the affinity of CD44 as a hyaluronan ligand is greatly enhanced by posttranslational modifications 56, 57 . Naive T cells express low to moderate levels of CD44 and this expression is rapidly increased upon activation 58 . Our study shows that naive T cells bind via CD44-hyaluronan interactions to C/S-stimulated HUVEC, but not to TNF-α-stimulated HUVEC. As CD44 on naive T cells is unlikely to have undergone post-translational modification, it is probable that the enhanced CD44-hyaluronan interactions are due to high levels of hyaluronan induced on the endothelial cell surface by the HRS cell-derived factors. Alternatively, C/S-stimulation might have induced the expression of a different molecular weight hyaluronan on the HUVEC. The addition to c-Jun expression 12 , there is also intense cytoplasmic and nuclear c-Fos expression in HRS cells in cHL lymph nodes.
In conclusion, we show that LTα, a cytokine involved in lymph node maintenance, is an important HRS cell-derived mediator that stimulates endothelial cell activation in cHL. Inhibition of LTα activity may provide an approach to reduce inflammatory cell recruitment and disrupt signals essential for HRS cell survival in cHL.
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